Monica Farley, MD

Dr. Farley leads a large infectious diseases division at Emory made up of nearly 70 faculty members with a large research portfolio. She is an international expert in clinical disease and pathogenesis of Haemophilus Influenzae and Streptococcus pneumoniae. She serves as the academic Principal Investigator for the Georgia Emerging Infections Program (EIP), a CDC-funded surveillance network of ten national sites conducting applied epidemiologic and laboratory research focused on invasive bacterial pathogens (many vaccine preventable), influenza, foodborne diseases, and healthcare-associated infections, with a focus on antibiotic resistant infections and C. difficile. She is Past-President of the American Federation for Medical Research and a longstanding council member and Past-President of the Southern Society for Clinical Investigation. She has served on the Women’s Committee, the Program Planning Committee and the Public Health Committee in IDSA. She is a past member of the US Food and Drug Administration (FDA) Advisory Committee on Vaccines and Related Biological Products and she currently serves on the Pneumococcal Vaccine Working Group for CDC’s Advisory Committee on Immunization Practices (ACIP). The collaborative EIP research program has been highly productive, providing population-based assessment of the epidemiology and risk factors for important bacterial infections, including adult and pediatric Group B streptococcal infections, pneumococcal disease and community-associated MRSA, and performing post-licensure vaccine effectiveness studies.